Kiniksa Pharmaceuticals L...

NASDAQ: KNSA · Real-Time Price · USD
33.36
0.08 (0.24%)
At close: Aug 15, 2025, 3:59 PM
33.38
0.06%
After-hours: Aug 15, 2025, 04:54 PM EDT

Kiniksa Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
17.83M 8.54M -8.89M -12.69M -3.91M -17.7M 25.24M -13.86M 14.97M -12.27M 4.46M 224.09M -19.98M -25.21M -36.33M -30.54M -41.56M -49.48M
Depreciation & Amortization
-231K 345K 400K 399K 430K 466K 236K 603K 602K 596K 602K 493K 651K 656K 668K 658K 717K 312K
Stock-Based Compensation
8.88M 7.75M 8.3M 7.83M 7.36M 7.21M 7.77M 6.79M 6.47M 6.12M 6.37M 6.04M 6.68M 6.03M 6.13M 6.2M 5.72M 7.13M
Other Working Capital
n/a -4.42M 41.34M 2.95M 397K 2.13M 12.57M -9.33M 12.54M 3.36M -21.91M 15.74M -10.1M 14.27M 8.26M -3.1M -8.02M 839K
Other Non-Cash Items
-1.03M 2.7M 1.59M 267K 19.15M 2.76M 749K 2.15M -383K -45K 595K 642K 856K 899K 886K 702K 793K 1M
Deferred Income Tax
2.64M 2.99M -3.16M -3.64M 10.57M 4.37M -25.71M 10.29M -19.44M 1.08M 348K -185.84M n/a n/a 11K 14K -10K 10K
Change in Working Capital
n/a 1.6M 20.54M 5.6M -9.91M 8.58M -3.96M 11.01M -5.96M 260K -23.95M 16.63M 3.97M -19.22M 9.75M -5.54M -4.44M 911K
Operating Cash Flow
28.09M 22.32M 18.77M -2.24M 5.17M 3.99M 4.33M 16.99M -3.74M -4.27M -11.58M 62.05M -7.82M -36.85M -18.88M -28.51M -38.78M -40.12M
Capital Expenditures
-165K -99K -193K n/a n/a -84K -56K -16K -34K -24K 32K -22K -115K n/a -251K -51K -59K -20.05M
Cash Acquisitions
n/a n/a n/a -25K 25K n/a 14.84M 12.26M -35.57M 37.9M 10K -10K 91K n/a 20M n/a n/a 20M
Purchase of Investments
-34.32M -95.47M -21.99M -54.48M -89.26M -36.28M -60.82M -53.09M -38.13M -52.9M -62.8M -17.33M -25.51M -30.22M -59.79M n/a -23.1M -74.36M
Sales Maturities Of Investments
30.61M 44.03M 87.48M 48.13M 42.44M 61.88M 45.98M 40.83M 73.7M 15M 20.1M 36.4M 63.8M 7.5M 10M 47.9M 109.15M 139.25M
Other Investing Acitivies
n/a n/a n/a 25K -46.8M 25.61M -14.84M -12.26M 35.57M -37.9M -42.69M 19.06M 38.38M -22.72M -20M 47.9M 86.05M -20M
Investing Cash Flow
-3.88M -51.54M 65.29M -6.35M -46.8M 25.52M -14.89M -12.28M 35.53M -37.92M -42.66M 19.04M 38.27M -22.72M -50.04M 47.85M 85.99M 44.83M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a -412K -578K -2.71M -1.31M -381K -262K -1.1M -419K -420K -100K -208K -24K -569K 5.88M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
10.7M 2.77M 2.72M 9.4M 1.14M 3.99M 957K 1.66M 577K 510K -901K 569K 566K 992K 1.21M -1.99M 887K 1.11M
Financial Cash Flow
10.7M 2.77M 2.14M 6.69M -178K 3.61M 695K 552K 158K 90K 1.19M 361K 542K 423K 1.21M 2.68M 887K 1.11M
Net Cash Flow
34.91M -26.45M 86.2M -1.9M -41.81M 33.12M -9.87M 5.26M 31.95M -42.1M -53.05M 81.45M 30.98M -59.15M -67.71M 22.02M 48.1M 5.82M
Free Cash Flow
27.93M 22.23M 18.58M -2.24M 5.17M 3.9M 4.27M 16.97M -3.78M -4.29M -11.54M 62.03M -7.94M -36.85M -19.14M -28.56M -38.84M -60.18M